https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2015-06-15 17:07:482020-05-27 11:39:56IOZK Fallstudie zum Langzeitüberleben einer Patientin mit Brustkrebs
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-322015-06-13 00:00:002021-11-15 13:28:49Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2015-06-12 17:06:232019-02-12 17:07:27Beitrag von Prof. Dr. Schirrmacher in der Wiener medizinischen Wochenschrift „Skriptum“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-28 / Immunotherapy 2015;7(8):855-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-28 / Immunotherapy 2015;7(8):855-602015-05-28 00:00:002021-11-16 07:55:05Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2015-04-12 17:11:582019-02-12 17:12:51IOZK erhält Herstellungserlaubnis für den patienteneigenen Tumorimpfstoff
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-01-15 / J Cancer 2015;6(3):203-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-01-15 / J Cancer 2015;6(3):203-172015-01-15 00:00:002021-11-15 13:29:28Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2014-11-30 17:15:002019-02-12 17:15:38Prof. Dr. Schirrmacher veröffentlicht E-Book: Harnessing Oncolytic Virus-mediated Antitumor Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2014-10-24 17:16:162019-02-12 18:55:16IOZK Fallstudie über die erfolgreiche Behandlung eines metastasierten Prostatakarzinoms
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-72014-10-06 00:00:002021-11-15 16:54:44Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-24062014-10-06 00:00:002021-11-16 07:53:33Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
